Canlyniadau Chwilio - Breitbart, Eyal
- Dangos 1 - 9 canlyniadau o 9
-
1
-
2
-
3
-
4
-
5
NT-07 PHASE 1-2 DOSE-ESCALATION STUDY OF VB-111, AN ANTI-ANGIOGENIC GENE THERAPY, AS MONOTHERAPY AND IN COMBINATION WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA gan Brenner, Andrew, Cohen, Yael, Vredenburgh, James, Peters, Katherine, Blumenthal, Deborah, Bokstein, Felix, Breitbart, Eyal, Bangio, Livnat, Sher, Naamit, Harats, Dror, Wen, Patrick
Cyhoeddwyd 2014Text -
6
ATIM-03. BIOMARKER ANALYSIS SUPPORTS THE VB-111 DUAL MECHANISM OF ACTION gan Gruslova, Aleksandra, Liu, Yichu, Wen, Patrick, Peters, Katherine B, Vredenburgh, James, Bokstein, Felix, Blumenthal, Deborah T, Cohen, Yael, Mendel, Itzhak, Breitbart, Eyal, Brenner, Andrew
Cyhoeddwyd 2017Text -
7
VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme gan Gruslova, Aleksandra, Cavazos, David A, Miller, Jessica R., Breitbart, Eyal, Cohen, Yael C, Bangio, Livnat, Yakov, Niva, Soundararajan, Anu, Floyd, John R., Brenner, Andrew J.
Cyhoeddwyd 2015Text -
8
Transcription-controlled gene therapy against tumor angiogenesis gan Greenberger, Shoshana, Shaish, Aviv, Varda-Bloom, Nira, Levanon, Keren, Breitbart, Eyal, Goldberg, Iris, Barshack, Iris, Hodish, Israel, Yaacov, Niva, Bangio, Livnat, Goncharov, Tanya, Wallach, David, Harats, Dror
Cyhoeddwyd 2004Text -
9
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study gan Brenner, Andrew J, Peters, Katherine B, Vredenburgh, James, Bokstein, Felix, Blumenthal, Deborah T, Yust-Katz, Shlomit, Peretz, Idit, Oberman, Bernice, Freedman, Laurence S, Ellingson, Benjamin M, Cloughesy, Timothy F, Sher, Naamit, Cohen, Yael C, Lowenton-Spier, Noa, Rachmilewitz Minei, Tamar, Yakov, Niva, Mendel, Itzhak, Breitbart, Eyal, Wen, Patrick Y
Cyhoeddwyd 2020Text